Further, high CAIX expression was associated with significantly worse prognosis in glioma patients (data retrieved from the REMBRANDT (Repository of Molecular Brain Neoplasia Data, NCI; Figure 1C). This evidence concerns the gene CA9 and central nervous system cancer.